LRMR R&D Expenses
Larimar Therapeutics Inc · R&D Expenses
LRMR R&D Expenses
Latest reported$157.34Mperiod ending
LRMR TTM R&D Expenses ($54.62M → $157.34M)
TTM R&D Expenses
High-resolution chart · PNG
LRMR r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 157,335,000 | |
| 152,703,000 | |
| 154,224,000 | |
| 121,589,000 | |
| 90,577,000 | |
| 86,891,000 | |
| 73,198,000 | |
| 57,027,000 | |
| 49,693,000 | |
| 35,886,000 | |
| 27,589,000 | |
| 24,240,000 | |
| 23,237,000 | |
| 23,006,000 | |
| 24,250,000 | |
| 23,324,000 | |
| 31,770,000 | |
| 35,228,000 | |
| 38,396,000 | |
| 42,678,000 | |
| 35,569,000 | |
| 35,374,000 | |
| 31,407,000 | |
| 26,239,000 | |
| 27,354,000 | |
| 21,575,000 | |
| 16,572,222 | |
| 22,623,222 | |
| 26,419,222 | |
| 35,500,222 | |
| 47,929,000 | |
| 47,383,000 | |
| 45,276,000 | |
| 43,595,000 | |
| 40,839,000 | |
| 37,203,000 | |
| 37,481,000 | |
| 37,116,000 | |
| 39,936,000 | |
| 50,367,000 | |
| 54,537,000 | |
| 56,900,000 | |
| 54,618,000 | |
| 48,988,000 | |
| 39,512,000 |